Cost-Effectiveness of Current Colorectal Cancer Screening Tests. Gastrointestinal endoscopy clinics of North America Ladabaum, U. n. 2020; 30 (3): 479–97


Cost-effectiveness analysis compares benefits and costs of different interventions to inform decision makers. Alternatives are compared based on an incremental cost-effectiveness ratio reported in terms of cost per quality-adjusted life-year gained. Multiple cost-effectiveness analyses of colorectal cancer (CRC) screening have been performed. Although regional epidemiology of CRC, relevant screening strategies, regional health system, and applicable medical costs in local currencies differ by country and region, several overarching points emerge from literature on cost-effectiveness of CRC screening. Cost-effectiveness analysis informs decisions in ongoing debates, including preferred age to begin average-risk CRC screening, and implementation of CRC screening tailored to predicted CRC risk.

View details for DOI 10.1016/j.giec.2020.02.005

View details for PubMedID 32439083